RESEARCH TRIANGLE PARK, N.C. – Bayer CropScience (www.bayercropscience.us), one of the world’s top innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits, has announced that it is a presenting/season sponsor of the North Carolina Theatre. Bayer is donating more than $25,000 to the theatre this season. The North Carolina Theatre’s mission is to strengthen the cultural vitality of North Carolina by cultivating musical theatre appreciation. It strives to produce outstanding professional Broadway musicals and to develop the next generation of artists through youth training, performance and outreach programs.
Bayer CropScience is committed to making a positive difference in the communities where its employees live and work. Over the years, it has sponsored a variety of cultural and educational events as part of its commitment to valuing people and their different perspectives and cultures.
“Bayer CropScience is proud to be a sponsor of the North Carolina Theatre,” said William Buckner, Bayer CropScience CEO. “We are committed to supporting the arts both now and in the future. The North Carolina Theatre does a wonderful job entertaining audiences and inspiring future thespians.”
- For more information about the NC Theatre, visit www.nctheatre.com.
ABOUT BAYER CROPSCIENCE:
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 6.830 billion (2010), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 20,700 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
MMI Public Relations